One-Year Outcomes in "real-World" Patients Treated with a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study [PE-Plus PAS])

American Journal of Cardiology

Volumn 117, Issue 4, 2016, Pages 539-545

  Kandzari, David E ^a   Amjadi, Nima ^b   Caputo, Christopher ^c   Rowe, Steven K ^d   Williams, Jerome ^e   Tamboli, Hoshedar P ^f   Christen, Thomas ^g   Allocco, Dominic J ^g   Dawkins, Keith D ^g  

^a PIEDMONT HOSPITAL   (United States)

^b Austin AI   (United States)

^c North Florida Regional Medical Center   (United States)

^d Interventional Cardiology   (United States)

^e Presbyterian Medical Center   (United States)

^f Brandon Regional Hospital   (United States)

^g BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; CHROMIUM; IMMUNOSUPPRESSIVE AGENT; PLATINUM; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DIABETIC PATIENT; EVEROLIMUS ELUTING CORONARY STENT; EVEROLIMUS ELUTING PLATINUM CHROMIUM CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; TASK PERFORMANCE; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEVICE APPROVAL; DRUG ELUTING STENT; MIDDLE AGED; PROCEDURES; PROSTHESIS DESIGN; RADIOGRAPHY; REGISTER; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHROMIUM; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEVICE APPROVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATINUM; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84958871213     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.11.043     Document Type: Article

References (17)

1. G.W. Stone, P.S. Teirstein, I.T. Meredith, B. Farah, C.L. Dubois, R.L. Feldman, J. Dens, N. Hagiwara, D.J. Allocco, K.D. Dawkins PLATINUM Trial Investigators A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two de Novo Coronary Artery Lesions) trial J Am Coll Cardiol 57 2011 1700 1708
2. I.T. Meredith, R. Whitbourn, D. Scott, S. El-Jack, R. Zambahari, G.W. Stone, P.S. Teirstein, R.M. Starzyk, D.J. Allocco, and K.D. Dawkins PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses EuroIntervention 7 2011 84 90
3. S. Saito, N. Hagiwara, A. Seki, K. Igarashi, T. Muramatsu, J. Yajima, H. Yokoi, M. Nakamura, K. Fujii, T. Isshiki, G.W. Stone, P.S. Teirstein, I.T. Meredith, D.J. Allocco, and K.D. Dawkins Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stents J Cardiol 64 2014 105 112
4. P.S. Teirstein, I.T. Meredith, R.L. Feldman, A.C. Rabinowitz, L.A. Cannon, T.C. Lee, J. Dens, C.L. Dubois, M.R. Mooney, V.J. Pompili, S. Saito, D.J. Allocco, K.D. Dawkins, and G.W. Stone Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions Catheter Cardiovasc Interv 85 2014 207 215
5. PROMUS Element Plus Everolimus-eluting Platinum Chromium Coronary Stent System Directions for Use, Boston Scientific, 2011.
6. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, and H.H. Ting 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 2574 2609
7. M.R. Thomas, R. Birkemeyer, P. Schwimmbeck, V. Legrand, R. Moreno, C. Briguori, N. Werner, E. Bramucci, I. Ungi, G. Richardt, P.L. Underwood, and K.D. Dawkins One-year outcomes in 1010 unselected patients treated with the PROMUS element everolimus-eluting stent: the multicentre PROMUS element European Post-Approval surveillance study EuroIntervention 10 2015 1267 1271
8. G.W. Stone, A. Rizvi, W. Newman, K. Mastali, J.C. Wang, R. Caputo, J. Doostzadeh, S. Cao, C.A. Simonton, K. Sudhir, A.J. Lansky, D.E. Cutlip, D.J. Kereiakes SPIRIT IV Investigators Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. D.P. Lee, R. Paulus, K. Giri, J. Carr, K.W. Baran, D. Hassel, K.J. Winters, T. Christen, K.D. Dawkins, and K.N. Garratt Primary Endpoint Results of the TAXUS Libertě Post Approval Study. TCT-167 2013 Transcatheter Cardiovascular Therapeutics San Francisco
11. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, C. Stettler, D. Sangiorgi, F. D'Ascenzo, T. Kimura, C. Briguori, M. Sabate, H.S. Kim, A. De Waha, E. Kedhi, P.C. Smits, C. Kaiser, G. Sardella, A. Marullo, A.J. Kirtane, M.B. Leon, and G.W. Stone Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
12. S.H. Kang, K.W. Park, D.Y. Kang, W.H. Lim, K.T. Park, J.K. Han, H.J. Kang, B.K. Koo, B.H. Oh, Y.B. Park, D.E. Kandzari, D.J. Cohen, S.S. Hwang, and H.S. Kim Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis Eur Heart J 35 2014 1147 1158
13. T. Palmerini, U. Benedetto, G. Biondi-Zoccai, D. Della Riva, L. Bacchi-Reggiani, P.C. Smits, G.J. Vlachojannis, L.O. Jensen, E.H. Christiansen, K. Berencsi, M. Valgimigli, C. Orlandi, M. Petrou, C. Rapezzi, and G.W. Stone Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis J Am Coll Cardiol 65 2015 2496 2507
14. D.J. Kereiakes, D.E. Cutlip, R.J. Applegate, J. Wang, M. Yaqub, P. Sood, X. Su, G. Su, N. Farhat, A. Rizvi, C.A. Simonton, K. Sudhir, and G.W. Stone Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) J Am Coll Cardiol 56 2010 2084 2089
15. E. Grube, B. Chevalier, G. Guagliumi, P.C. Smits, M. Stuteville, C. Dorange, P. Papeleu, U. Kaul, and V. Dzavik The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberte paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions Am Heart J 163 2012 867 875 e1
16. R. Moreno, M.R. Thomas, R. Birkemeyer, P. Schwimmbeck, V. Legrand, C. Briguori, N. Werner, E. Bramucci, I. Ungi, G. Richardt, P. Underwood, and K. Dawkins One-year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study, EuroPCR 2013 Paris, France
17. D.J. Kereiakes, J. Popma, L. Cannon, D. Kandzari, C. Kimmelstiel, I.T. Meredith, P.S. Teirstein, S. Verheye, D.J. Allocco, K.D. Dawkins, and G. Stone Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials EuroIntervention 8 2012 187 195